Cargando…
Pharmacokinetics of Pimobendan and Its Metabolite O-Desmethyl-Pimobendan Following Rectal Administration to Healthy Dogs
Objective: This study describes the pharmacokinetics of parent pimobendan (PIM) and its active metabolite, o-desmethyl-pimobendan (ODMP), after oral and rectal administration of pimobendan to healthy dogs. Animals: A total of eight healthy privately owned dogs were used in this study. Procedures: Th...
Autores principales: | Her, Jiwoong, Kuo, Kendon W., Winter, Randolph L., Cruz-Espindola, Crisanta, Bacek, Lenore M., Boothe, Dawn M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7417621/ https://www.ncbi.nlm.nih.gov/pubmed/32851013 http://dx.doi.org/10.3389/fvets.2020.00423 |
Ejemplares similares
-
Pharmacodynamics and Pharmacokinetics of Injectable Pimobendan and Its Metabolite, O-Desmethyl-Pimobendan, in Healthy Dogs
por: Pichayapaiboon, Poonavit, et al.
Publicado: (2021) -
Hemodynamic effect of pimobendan following intramuscular and intravenous administration in healthy dogs: A pilot study
por: Enokizono, Masayuki, et al.
Publicado: (2022) -
Effects of pimobendan on left atrial transport function in cats
por: Kochie, Samantha L., et al.
Publicado: (2020) -
Pharmacokinetics of pimobendan after oral administration to dogs with myxomatous mitral valve disease
por: McManamey, Anna K., et al.
Publicado: (2023) -
Pharmacokinetics of mebendazole in plasma and cerebrospinal fluid following a single oral dose in healthy dogs
por: Yanke, Amy B., et al.
Publicado: (2023)